生物标志物 生物标志物
Caroline Dallaire-Théroux1, Rosalie Cottez1,2, Olivier Potvin3
1Université Laval / CHU de Québec, Quebec City, QC, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
血清胎盘生长因子 (PlGF) 在阿尔茨海默病 (AD) 患者中显示出作为脑血管疾病 (CVD) 的生物标志物,特别是脑微血,具有前途. 它的关联在男性和APOE4载体中最强.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 血管生物学 血管生物学
背景情况:
- 阿尔茨海默病 (AD) 生物标志物研究往往忽略了血管因素.
- 血管新生标志物,如胎盘生长因子 (PlGF),有望检测血管对AD的贡献.
- PlGF参与血管化,透性,并对大脑缺血反应.
研究的目的:
- 调查血清PlGF水平与MRI定义的大脑血管疾病 (CVD) 标志物在认知障碍和AD患者之间的关联.
- 探索PlGF,血管风险因素,认知状态和AD生物标志物之间的潜在相关性.
主要方法:
- 血清PlGF测量了主观认知障碍,轻度认知障碍,早期AD和对照组的参与者.
- 评估了心血管疾病的MRI标志物,包括白质强度过高 (WMH) 量和微型血液.
- 统计分析,包括ANOVA和回归模型,检查了PlGF,临床群体,人口统计,血管因素和AD生物标志物之间的关系.
主要成果:
- 男性的血清Plgf水平较高,并且随年龄增加,但在临床组之间没有显著差异.
- PlGF与腰部尺寸,体重,甘油三和腹压血压呈现趋势的正相关性.
- PlGF水平与全脑和深脑小脑微型血液相关,但没有WMH. 这种关联在APOE4载体和男性中持续存在.
结论:
- 血清PlGF是心血管疾病的潜在生物标志物,特别是阿尔茨海默病中的脑微型血液.
- PlGF在心血管疾病中的作用在特定的亚群中可能特别重要,例如APOE4载体.
- 了解PlGF与心血管疾病的联系对于监测AD新疗法的安全性和有效性至关重要.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511


